A naphthyridine and fluoroquinolone derivative antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used for the treatment of community-acquired pneumonia and acute bacterial infections associated with chronic bronchitis.
Pharmacology effect
antibiotiká inhibítory topoizomerázy II
Pharmacology effect
Anti-Bacterial Agents Topoisomerase II Inhibitors
subject heading
Number of the records: 1
openseadragon
This site uses cookies to make them easier to browse. Learn more about
how we use cookies.
